The Patent Finder

Action Medicines, S.L.

Also on record
Records under this name other than patents Action Medicines, S.L. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Action Medicines, S.L.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,511,044Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of skin cancer
Formerly held
Lapsed on the fee record
Ended Dec 6, 2024 · USPTO record
Lapsed on the fee recordEnded Dec 6, 2024USPTO record
US 10,632,085Processes for the preparation of 2,5-dihydroxybenzenesulfonic acid salts
Formerly held
Lapsed on the fee record
Ended Apr 28, 2024 · USPTO record
Lapsed on the fee recordEnded Apr 28, 2024USPTO record
US 9,248,114Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of hematological dyscrasias and cancer of an organ
Lapsed on the fee record
Ended Feb 2, 2024 · USPTO record
Lapsed on the fee recordEnded Feb 2, 2024USPTO record
US 8,101,660Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of skin cancer
Formerly held
Lapsed on the fee record
Ended Jan 24, 2024 · USPTO record
Lapsed on the fee recordEnded Jan 24, 2024USPTO record
US 9,227,928Processes for the preparation of 2,5-dihydroxybenzenesulfonic acid salts
Formerly held
Lapsed on the fee record
Ended Jan 5, 2024 · USPTO record
Lapsed on the fee recordEnded Jan 5, 2024USPTO record
US 9,192,592Use of 2,5-dihydroxybenzene derivatives for treating dermatitis
Lapsed on the fee record
Ended Nov 24, 2023 · USPTO record
Lapsed on the fee recordEnded Nov 24, 2023USPTO record
US 10,441,530Skin penetration enhancing systems for polar drugs
Formerly held
Lapsed on the fee record
Ended Oct 15, 2023 · USPTO record
Lapsed on the fee recordEnded Oct 15, 2023USPTO record
US 10,434,076Use of 2,5-dihydroxybenzene derivatives for treating dermatitis
Lapsed on the fee record
Ended Oct 8, 2023 · USPTO record
Lapsed on the fee recordEnded Oct 8, 2023USPTO record
US 7,968,531Use of 2,5-dihydroxybenzenesulphonic acid in the production of medicaments for the treatment of angiodependent diseases such as cancer and psoriasis
Formerly held
Lapsed on the fee record
Ended Jun 28, 2023 · USPTO record
Lapsed on the fee recordEnded Jun 28, 2023USPTO record
US 10,278,940Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of skin cancer
Formerly held
Lapsed on the fee record
Ended May 7, 2023 · USPTO record
Lapsed on the fee recordEnded May 7, 2023USPTO record
10 of 26 patents shown.
Pro members see all 26.
Pro members: see all 26 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited